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Disease  Control
o Infectious disease control program directed 
toward:
o Biosecurity
o Reducing exposure; Infection control
o Minimizing factors that reduce resistance 
(stress, poor nutrition)
o Enhancing resistance by vaccination
o Herd immunity
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Vaccination Considerations
o No “standard” program
o Must be based on disease risk
– Anticipated exposure
– Environmental & geographic factors
– Age, breed & sex
o Factor in expected efficacy & cost
o Aid in preventing infectious diseases 
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Vaccination Considerations
Storage and handling per manufactures’ 
instructions
– Proper temp.
– Don’t use outdated vaccines
Injection site should be clean
Use separate new needle for each animal
Vaccination Considerations
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Vaccination = 
immunization
Vaccine Response
The vaccine itself
Individual horses immune system
– ~10% respond poorly to vaccination
Vocation of the horse
Age
– Foal- maternal antibodies
– Geriatric- >20yrs, immunosenescence
• Diminished immune response
• Lower total lymphocytes and Ig conc
Vaccine Response
Health status
Immune suppression
– Long distance transport
– Medications
– PPID
Response to vaccine not immediate
– Must mount immunologic response
– At least 14 days
Vaccine Response
Most vaccines require 2 doses for primary 
immunization 
– 4-6weeks apart
– Optimum response 2 weeks after 2nd dose
Most vaccines require annual booster
Monovalent vs Multivalent
Most horses have adequate response from 
multivalent vaccines
Some circumstances may want monovalent
– Some evidence slightly better response
• Based on PRNT titer
– Specific disease exposure
– Vaccine reaction 
Vaccinate vs Do Not Vaccinate
Started in Human Medicine now in Veterinary 
Medicine
Titers used to determine need for vaccination
– Plaque reduction neutralization test –PRNT
– Protective levels of immunity not defined 
– Correlation between Ab levels and protective 
immunity under field conditions not deffined
Vaccine Administration
 Only vaccinate healthy horses
 Follow manufacturer’s recommendations
 IM vaccines given deep in the muscle
– 1.5 inch needle, 20g
– Neck or hamstring 
 Don’t use outdated vaccine
 Store vaccines properly
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Vaccination Considerations
Don’t assume complete protection during a disease 
outbreak
Protection is not immediately afforded the patient 
– Multiple doses necessary to prime the immune system
Each horse is different
– Degree of protection
– Duration of protection 
Adverse reactions rare but possible
Vaccination
AAEP guidelines for foals
 Initial series of 3 doses
 1st at 4-6 months
 2nd in 4-6 weeks
 3rd at 10-12 months
 If mare was not vaccinated or no vaccine 
history then start at 3-4 months
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Vaccines Available
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Tetanus EVA
Rhinopneumonitis
(1 & 4)
Influenza
Potomac horse fever Strangles
Botulism Rabies
EEE, WEE, VEE WNV
Rotavirus A Anthrax
Leptospirosis
Core Vaccines
AAEP
 Tetanus
 Rabies
 West Nile
 WEE (Western Equine Encephalomyelitis)
 EEE (Eastern Equine Encephalomyelitis)
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Vaccination programs should be 
developed in consultation with 
your veterinarian.
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Equine Encephalitides
(Sleeping Sickness)
Equine Encephalomyelitis Viruses
– Eastern (EEE)
– Western (WEE)
– Venezuelan (VEE)
– West Nile virus
Occurrence of disease is seasonal
Maintenance Cycle– mosquitoes and wild birds 
(small mammals, reptiles)
Equine Encephalomyelitis
o Humans susceptible
o Humans/Equine dead-end hosts 
-> Yes for WEE, EEE, WNV    
-> NOT for VEE 
o Mortality rate varies
– EEE --- 50 to 90%    
– WEE --- 20 to 50%      
– VEE --- 40 to 80%
– WNV--- 20 to 40% 
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West Nile Virus
First Dx in U.S. in 1999
– New York
– Within 4 yrs all continental US, Canada, 
Mexico
Leading cause of mosquito transmitted 
encephalitis in horses and humans in U.S
 Since 1999 over 25,000 cases of WNV 
encephalitis reported in U.S. horses
West Nile Virus
Occurrence of disease is seasonal
– Climatic change
Maintenance Cycle– mosquitoes and wild birds 
WNV: Retrospective Look
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West Nile Virus
Incubation period– 3 to 15 days
Clinical disease develops in anywhere from 
10% to 39% of unvaccinated horses
Fatality rate is approx. 33%
40% of horses that survive exhibit residual 
effects 6 months post-diagnosis
WNV Clinical Signs
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 Fever   Anorexia
Sleepiness  Behavior changes
 Incessant walking  Ataxia, Circling
 Muscle twitching
Blindness Head pressing
Recumbuncy Very similar to rabies
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Diagnosis and Treatment of WNV
Postmortem Dx
– qPCR; virus isolation
Serological
– IgM capture ELISA;PRNT;SN
Symptomatic (treat the symptoms)
– Anti-inflammatory drugs
– IV fluids
– Other support therapies
Prevention of VNV, EEE, WEE
Vaccination – very effective vaccine
Mosquito control
 Insect repellent sprays 
WNV: Retrospective Look
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Parasite Control
Commonly used strategies developed based on 
knowledge that is 40 years old
Parasitic fauna of the horse has changed
– Large stronglyes (Strongylus vulgaris) now rare
– Small strongyles (cyathostomins) now major 
parasite in adult horses
– Ascarids (Parascaris spp.) still most important 
parasite in foals and weanlings
Parasite Control
Traditional parasite control program
– Based on large strongyle (S.vulgaris) 
– Kill parasite before it could mature and lay eggs
– Took about 2 months for eggs to reappear after 
treatment
– Treat every 2 months; very successful
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Small strongyles
 Virtually all grazing horses are infected
 Relatively mild pathogen
 Produce disease when in high numbers 
#1 culprit 
in horse  
parasite 
world
Parasite Control
Anthelmintic resistance is prevalent in 
cyathostomins and ascarids.
Variation in adult horses concerning innate 
resistance to infection
Horses less than about 3 years of age are more 
susceptible to parasite infection
Anthelmintic Resistance
The ability of worms in a population to survive 
treatments that are generally effective
Inherited trait
Rate of development determined by selection 
pressure and passing genes to next gereration
Resistance genes increase to point of tx failure
Once present resistant parasites do not revert
Parasite Refugia
The portion of a population of parasites that 
escapes selection with the drug during a treatment 
event
More worms in refugia the more slowly resistance 
develops
Worms in refugia not selected for resistance
Resistance worms diluted by susceptible worms
Strongyle Egg Shedding
Horses demonstrate differences in egg shedding
Egg counts highly conc in certain horses
– 20% of the horses shed 80% of the eggs
– Individuals tend to be consistent
Fecal egg counts are necessary to properly 
develop and monitor a parasite control program
Goals of Parasite Control
Limit parasite infections so animals remain 
healthy and clinical illness doesn’t develop
Not to eradicate all parasites from a horse
– Impossible
– Inevitable result is drug resistance
Control parasite egg shedding
Avoid further development of anthelmintic 
resistance
Goal of Parasite Control Program
Minimize the risk of parasitic disease
Control parasite egg shedding
Maintain efficacious drugs
Avoid further anthelmintic resistance as much as 
possible
Eradication of parasites from an individual is not 
the goal(impossible) and inevitably results in 
accelerated development of parasite drug 
resistance.

